NASDAQ · Biotechnology

Canton Strategic Holdings, Inc. (CNTN) Stock

$2.11 +1.44% NASDAQ: CNTN Healthcare

Valuation

MetricValue
Price$2.11
Market Cap$162.73M
P/E Ratio-1.43
P/B Ratio1.07
P/S Ratio116.00
EPS (TTM)$0.00
52-Week High$6.89
52-Week Low$1.75
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE-29.54%
ROA-17.38%
ROCE-9.57%
Gross Margin0.00%
Operating Margin0.00%
Net Margin0.00%
Debt/Equity0.00
Current Ratio5.67

Annual Financials (USD)

Metric20212022202320242025
Revenue$0$0$0$0$0
Operating Profit$-3.0M$-7.0M$-9.0M$-12.0M$-20.0M
Net Profit$-2.0M$-8.0M$-9.0M$-12.0M$-36.0M
EPS$-72.81$-280.77$-107.08$-9.41$-1.12
Op Margin—————

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$1.0M$7.0M$11.0M$4.0M$519.0M
Total Liabilities$5.0M$1.0M$2.0M$2.0M$121.0M
Cash$0$7.0M$11.0M$4.0M$17.0M
Borrowings$2.0M$0$0$0$0

Latest News

Tharimmune Stockholders Elect Board, Ratify Auditor at 2026 Annual Meeting MarketBeat · Jul 14, 2026 Canton Strategic Holdings, Inc. Announces Launch of Locking Service to Support Network Infrastructure Providers PR Newswire · Jun 23, 2026 We're Not Very Worried About Canton Strategic Holdings' (NASDAQ:CNTN) Cash Burn Rate Simply Wall St. · May 15, 2026 Tharimmune Highlights Canton Network Q1 Growth, Tokenomics Shift and Validator Locking in Webinar MarketBeat · Apr 26, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$-1.0M$-7.0M$-7.0M$-11.0M$-16.0M
Investing Cash Flow$0$0$0$0$-155.0M
Financing Cash Flow$0$-1.0M$-1.0M$-1.0M$-10.0M
Net Cash Flow$0$7.0M$4.0M$-7.0M$13.0M
Free Cash Flow$-1.0M$-7.0M$-7.0M$-11.0M$-94.0M

Valuation & Return Ratios

MetricValue
PEG Ratio-0.01
EV / EBITDA-1.55
FCF Yield-12.78%
Quick Ratio15.70
Interest Coverage-3921.73
Return 1Y38.99%
Return 3Y-98.37%
Return 5Y—

Ownership

Insiders Held17.51%
Institutions Held16.99%
Institutions Float Held20.60%
Institutional HolderSharesReport Date
ARK Investment Management, LLC3,695,0842026-03-31
Valor Management LLC1,084,0112026-03-31
Blackrock Inc.765,8292026-03-31
Sumitomo Mitsui Trust Group, Inc.728,1672026-03-31
Amova Asset Management Americas Inc728,1672026-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
ADAPAdaptimmune Therapeutics plc $0.05 -3.00% -0.16 $75.16M 0.00%
ADTX $0.01 -77.22% -0.01 $318 0.00%
AIMDAinos, Inc. $1.21 +0.00% -0.54 $8.91M 0.00%
ANLAdlai Nortye Ltd. $13.26 +2.00% -8.19 $703.84M 0.00%
APLMApollomics Inc. $21.50 -1.29% -2.84 $47.22M 0.00%

About Canton Strategic Holdings, Inc.

Canton Strategic Holdings, Inc. is led by CEO Mark Wendland, employs 2 people, headquartered in US, publicly traded since 2024.

Canton Strategic Holdings, Inc. (CNTN) stock trades at $2.11 with a market capitalization of $162.73M. The stock is valued at a price-to-earnings (P/E) ratio of -1.43, price-to-book of 1.07, price-to-sales of 116.00. Over the past 52 weeks the stock has ranged between $1.75 and $6.89, and currently trades 69.4% below its 52-week high.

On profitability, Canton Strategic Holdings, Inc. generates a return on equity (ROE) of -29.54%, return on capital employed of -9.57%, an operating margin of 0.00%, a net profit margin of 0.00%.

Related Healthcare Stocks

LLY Eli Lilly and Company $1179.27 +0.83% JNJ Johnson & Johnson $261.44 +1.93% ABBV AbbVie Inc. $276.47 +1.49% MRK Merck & Company, Inc. Common Stock (new) $145.60 +2.26% UNH UnitedHealth Group Incorporated Common Stock (DE) $379.30 +2.25% NVS Novartis AG $143.75 +0.45% AZN AstraZeneca PLC $159.20 +0.26% TMO Thermo Fisher Scientific Inc $658.02 +0.93% AMGN Amgen Inc. $414.87 +1.82% GILD Gilead Sciences, Inc. $151.17 +2.77% ABT Abbott Laboratories $99.60 +1.13% NVO Novo Nordisk A/S $38.64 +1.20%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNasdaq High ROE StocksAll stock screens
Run Stock Screener Investing Guides